Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - LONG-TERM DEBT
Long-term Debt EXEL - Exelixis, Inc.
191 M
LAST VALUE
0.17%
2 YEAR CAGR
31.78%
5 YEAR CAGR
-3.13%
10 YEAR CAGR